Spheroids, gray background. BIO-ONE experiment - Incucyte Campaign image

Automated Organoid Dispensing and Assay in Matrigel® Domes

Access the Technical Note

Automated Dispensing and Assay of Organoids in Matrigel® Domes

Authors: Kalpana Barnes (Sartorius UK, Royston, Hertfordshire, UK), Paulo Godoy (CELLINK Bioprinting AB, Gothenburg, Sweden) | Last Updated: April 2026

 

Technical Note Overview

This technical note describes an automated workflow for dispensing and assaying 3D organoids in Matrigel® domes using the CELLINK BIO ONE and Sartorius Incucyte® Live‑Cell Analysis System. By combining temperature‑controlled, low‑volume bio‑dispensing with continuous, non‑invasive live‑cell imaging, the workflow improves scalability, reproducibility, and throughput compared with manual methods. The approach enables consistent organoid formation, robust assay performance, and quantitative analysis of compound‑induced effects, supporting organoid‑based drug discovery and pharmacology applications.


Resource Details:

  • Document Type: Technical Note
  • Page Count: 8 pages
  • Read Time: 10 minutes


Access the Technical Note here

Key Takeaways

  1. Automated dispensing enables highly uniform Matrigel® domes across 96‑well plates
  2. Temperature‑controlled BIO ONE dispensing reduces variability and manual handling errors
  3. Incucyte® live‑cell imaging provides continuous, non‑invasive monitoring of organoid growth
  4. Robust, reproducible assays support compound profiling and mode‑of‑action studies
  5. Scalable workflow improves throughput and data quality for organoid‑based drug discovery

Preview Image for Tech Note